These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15119475)

  • 1. Pharmacologic treatment of autism.
    Palermo MT; Curatolo P
    J Child Neurol; 2004 Mar; 19(3):155-64. PubMed ID: 15119475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy of irritability in pervasive developmental disorders.
    Stigler KA; McDougle CJ
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):739-52, vii-viii. PubMed ID: 18775367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders.
    Soorya L; Kiarashi J; Hollander E
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):753-71, viii. PubMed ID: 18775368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of aggression in children and adolescents with autism and conduct disorder.
    McDougle CJ; Stigler KA; Posey DJ
    J Clin Psychiatry; 2003; 64 Suppl 4():16-25. PubMed ID: 12672261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy for social anxiety disorder: an update.
    Van Ameringen M; Mancini C; Patterson B; Simpson W
    Isr J Psychiatry Relat Sci; 2009; 46(1):53-61. PubMed ID: 19728573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication treatment in subjects with autistic spectrum disorders.
    Buitelaar JK; Willemsen-Swinkels SH
    Eur Child Adolesc Psychiatry; 2000; 9 Suppl 1():I85-97. PubMed ID: 11140783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of pervasive developmental disorders in children and adolescents.
    Masi G
    CNS Drugs; 2004; 18(14):1031-52. PubMed ID: 15584771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders].
    Baghdadli A; Gonnier V; Aussilloux C
    Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing drugs for core social and communication impairment in autism.
    Posey DJ; Erickson CA; McDougle CJ
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):787-801, viii-ix. PubMed ID: 18775370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders.
    Posey DJ; McDougle CJ
    Harv Rev Psychiatry; 2000; 8(2):45-63. PubMed ID: 10902094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The status of pharmacotherapy for autism spectrum disorders.
    Myers SM
    Expert Opin Pharmacother; 2007 Aug; 8(11):1579-603. PubMed ID: 17685878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychopharmacology of autistic spectrum disorders in children and adolescents.
    Nazeer A
    Pediatr Clin North Am; 2011 Feb; 58(1):85-97, x. PubMed ID: 21281850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic treatment of behavioral symptoms in autism and pervasive developmental disorders.
    Findling RL
    J Clin Psychiatry; 2005; 66 Suppl 10():26-31. PubMed ID: 16401147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability.
    Kolevzon A; Mathewson KA; Hollander E
    J Clin Psychiatry; 2006 Mar; 67(3):407-14. PubMed ID: 16649827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autism: current theories regarding its pathogenesis and implications for rational pharmacotherapy.
    Buitelaar JK; Willemsen-Swinkels SH
    Paediatr Drugs; 2000; 2(1):67-81. PubMed ID: 10937459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The pharmacological approach to the autistic spectrum].
    Morant A; Mulas F; Hernández S
    Rev Neurol; 2002 Feb; 34 Suppl 1():S64-7. PubMed ID: 12447792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic treatment for the core deficits and associated symptoms of autism in children.
    West L; Waldrop J; Brunssen S
    J Pediatr Health Care; 2009; 23(2):75-89. PubMed ID: 19232924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open trial of divalproex sodium in autism spectrum disorders.
    Hollander E; Dolgoff-Kaspar R; Cartwright C; Rawitt R; Novotny S
    J Clin Psychiatry; 2001 Jul; 62(7):530-4. PubMed ID: 11488363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel psychotropic medications in children: new toxicities to master.
    Jacobs ES; Dickstein DP; Liebelt EL
    Pediatr Emerg Care; 2001 Jun; 17(3):226-31. PubMed ID: 11437154
    [No Abstract]   [Full Text] [Related]  

  • 20. [Psychopharmacology of autism spectrum disorders].
    Poustka L; Banaschewski T; Poustka F
    Nervenarzt; 2011 May; 82(5):582-9. PubMed ID: 21484169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.